{"id":986633,"date":"2026-07-29T15:03:15","date_gmt":"2026-07-29T19:03:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/"},"modified":"2026-07-29T15:03:15","modified_gmt":"2026-07-29T19:03:15","slug":"greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/","title":{"rendered":"Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n MIAMI<\/span>, July 29, 2026<\/span> \/PRNewswire\/ — Global law firm Greenberg Traurig, P.A.<\/a>\u00a0advised Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides, in connection with its oversubscribed $275 million private placement financing.<\/p>\n

\n

\n \"Greenberg\n <\/p>\n<\/p><\/div>\n

The financing is expected to extend Entera Bio’s cash runway into 2030 and fully support Phase 3 registrational studies for EB613, the first oral PTH (1-34) peptide tablet in development for the treatment of osteoporosis, according to the company’s press release<\/a>.<\/p>\n

This financing is the largest publicly disclosed Israeli biotech private investment in public equity (PIPE) on record and the ninth largest publicly disclosed Israeli PIPE transaction across all industries, according to data compiled by Arx Capital Markets, Entera Bio’s investor relations firm.<\/p>\n

The Greenberg Traurig team representing Entera Bio in this transaction was led by Miami<\/a>Corporate Practice<\/a>\u00a0Co-Chair Drew M. Altman<\/a>\u00a0and Miami Corporate Shareholder Sami B. Ghneim<\/a>, with assistance from Miami Corporate Associate Angel A. Marcial<\/a>\u00a0and Tel-Aviv office<\/a>\u00a0Managing Shareholder Joey T. Shabot<\/a>.<\/p>\n

\n About Greenberg Traurig:<\/b>\u00a0Greenberg Traurig, LLP has approximately 3,200 lawyers across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm’s broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI “Best of the Best Recommended Law Firm” by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law<\/i>\u00a0Global 100, NLJ<\/i>\u00a0500, and Law360<\/i>\u00a0400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com<\/a>.<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe-302838075.html<\/a><\/p>\n

SOURCE Greenberg Traurig, LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire MIAMI, July 29, 2026 \/PRNewswire\/ — Global law firm Greenberg Traurig, P.A.\u00a0advised Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides, in connection with its oversubscribed $275 million private placement financing. The financing is expected to extend Entera Bio’s cash runway into 2030 and fully support Phase 3 registrational studies for EB613, the first oral PTH (1-34) peptide tablet in development for the treatment of osteoporosis, according to the company’s press release. This financing is the largest publicly disclosed Israeli biotech private investment in public equity (PIPE) on record and the ninth largest publicly disclosed Israeli PIPE transaction across all industries, according to data compiled by Arx Capital Markets, Entera Bio’s investor relations firm. … <\/p>\n

Continue reading “Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-986633","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGreenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire MIAMI, July 29, 2026 \/PRNewswire\/ — Global law firm Greenberg Traurig, P.A.\u00a0advised Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides, in connection with its oversubscribed $275 million private placement financing. The financing is expected to extend Entera Bio’s cash runway into 2030 and fully support Phase 3 registrational studies for EB613, the first oral PTH (1-34) peptide tablet in development for the treatment of osteoporosis, according to the company’s press release. This financing is the largest publicly disclosed Israeli biotech private investment in public equity (PIPE) on record and the ninth largest publicly disclosed Israeli PIPE transaction across all industries, according to data compiled by Arx Capital Markets, Entera Bio’s investor relations firm. … Continue reading "Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-29T19:03:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mmx.prnewswire.com\/media\/MS1777985\/Greenberg-Traurig-LLP-Logo.jpg?id=OA2800304\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE\",\"datePublished\":\"2026-07-29T19:03:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1777985\\\/Greenberg-Traurig-LLP-Logo.jpg?id=OA2800304\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/\",\"name\":\"Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1777985\\\/Greenberg-Traurig-LLP-Logo.jpg?id=OA2800304\",\"datePublished\":\"2026-07-29T19:03:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1777985\\\/Greenberg-Traurig-LLP-Logo.jpg?id=OA2800304\",\"contentUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1777985\\\/Greenberg-Traurig-LLP-Logo.jpg?id=OA2800304\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/","og_locale":"en_US","og_type":"article","og_title":"Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE - Market Newsdesk","og_description":"PR Newswire MIAMI, July 29, 2026 \/PRNewswire\/ — Global law firm Greenberg Traurig, P.A.\u00a0advised Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides, in connection with its oversubscribed $275 million private placement financing. The financing is expected to extend Entera Bio’s cash runway into 2030 and fully support Phase 3 registrational studies for EB613, the first oral PTH (1-34) peptide tablet in development for the treatment of osteoporosis, according to the company’s press release. This financing is the largest publicly disclosed Israeli biotech private investment in public equity (PIPE) on record and the ninth largest publicly disclosed Israeli PIPE transaction across all industries, according to data compiled by Arx Capital Markets, Entera Bio’s investor relations firm. … Continue reading \"Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-29T19:03:15+00:00","og_image":[{"url":"https:\/\/mmx.prnewswire.com\/media\/MS1777985\/Greenberg-Traurig-LLP-Logo.jpg?id=OA2800304","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE","datePublished":"2026-07-29T19:03:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/"},"wordCount":288,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1777985\/Greenberg-Traurig-LLP-Logo.jpg?id=OA2800304","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/","name":"Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1777985\/Greenberg-Traurig-LLP-Logo.jpg?id=OA2800304","datePublished":"2026-07-29T19:03:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/#primaryimage","url":"https:\/\/mmx.prnewswire.com\/media\/MS1777985\/Greenberg-Traurig-LLP-Logo.jpg?id=OA2800304","contentUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1777985\/Greenberg-Traurig-LLP-Logo.jpg?id=OA2800304"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/greenberg-traurig-advises-entera-bio-in-record-275m-israeli-biotech-pipe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/986633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=986633"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/986633\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=986633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=986633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=986633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}